4887.T
SAWAI GROUP HOLDINGS Co.,Ltd.
プライム · 医薬品 · 医薬品 · JP
JPY 1,572.50
+0.16%Year over year
Reported trailing growth
- Revenue
- +9.1%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- +537.6%
- Operating cash flow
- +5.0%
Forward estimates
Based on analyst estimates
- Revenue
- +0.9%
- EBITDA
- —
- EPS
- +873.2%
Three-year CAGR
- Revenue
- -0.8%
- EBITDA
- -25.4%
- EBIT
- -51.2%
- Net income
- -2.8%
- EPS
- -42.2%
- Free cash flow
- -28.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026